Oorsprong van het eerstegraads netwerk van Claude Ramoni
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Aerium Therapeutics, Inc.
Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Claude Ramoni via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor Founder | |
BEAM THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree | |
Andrew Alliance SA
Andrew Alliance SA Industrial MachineryProducer Manufacturing Andrew Alliance SA develops liquid handling solutions. Its product, Andrew, is a novel liquid handling robot designed for pipetting process. The firm's products include Andrew models, consumable dominos, protocol design, and enabling accessories. The company was founded by Piero Zucchelli, Giorgio Horak, and Antoine Jordan in March 2011 and is headquartered in Vernier, Switzerland. | Industrial Machinery | Director/Board Member Director/Board Member | |
OMEGA ALPHA SPAC | Financial Conglomerates | Founder Chief Executive Officer | |
OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Geneva | College/University | Doctorate Degree Doctorate Degree | |
University of Pavia | College/University | Graduate Degree | |
Pictet - Biotech | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
FoRx Therapeutics AG
FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology FoRx Therapeutics AG operates as a biotechnology company developing a new generation of cancer drugs focusing on novel deoxyribonucleic acid (DNA) Replication Stress pathways activated in cancer. The firm also provides research and development services. The company was founded by Thanos Halazonetis and Sotirios K. Sotiriou in 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Luxe Trading SA | Director/Board Member | ||
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member | |
SpineVision SA
SpineVision SA Medical SpecialtiesHealth Technology SpineVision SA develops and markets implants for the treatment of spinal disorders. It also designs instrumentation for the spinal treatments. Its products include Flex 2, Lumis, Plus/X-Plus, ULIS, Unithread, Spacevisions, and C3. The firm also offers solutions for spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. The company was founded by Gérard Vanacker on July 16, 1999 and is headquartered in Antony, France. | Medical Specialties | Director/Board Member | |
MEDIAN TECHNOLOGIES | Medical/Nursing Services | Director/Board Member | |
REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member | |
ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
TRANSLATE BIO, INC. | Biotechnology | Director/Board Member | |
IMMUNIC, INC. | Pharmaceuticals: Major | Director/Board Member | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Lifespan, Inc.
Lifespan, Inc. Medical/Nursing ServicesHealth Services Lifespan, Inc. provides healthcare services. The company was founded on January 27, 1997 and is headquartered in Palm Desert, CA. | Medical/Nursing Services | Director/Board Member | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Nucleate Bio, Inc. | Director/Board Member | ||
Aitia, Inc.
Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services GNS Healthcare, Inc. provides analytics solutions for the healthcare industry. The firm offers solutions for electronic health records, claims, clinical and incentive programs, reward, product development solutions for biopharmaceutical, diagnostic, consumer product, and medical device companies and publications, conference abstracts, and presentations. The company was founded by Colin Hill and Iya Khalil in 2000 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
Transcend Therapeutics
Transcend Therapeutics BiotechnologyHealth Technology Transcend Therapeutics is an American biotechnology company that discovers, develops, and delivers next-generation psychoactive medicines to work towards a world where people no longer suffer from neuropsychiatric disease. The company is located in the US. The company focuses on developing medicines that are accessible to a larger percentage of patients in need, specifically the tens of millions of patients who already take psychotropic medication. Transcend Therapeutics has real-world data for its lead compound, TSND-201, demonstrating robust responses in patients with PTSD. As a public benefit corporation, the company has pledged 10% of its founding shares towards nonprofits focused on scientific research and patient access. | Biotechnology | Director/Board Member | |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Biotechnology | Founder | |
Mahzi Therapeutics, Inc.
Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
BLACKSTONE INC. | Investment Managers | Consultant / Advisor | |
Ariadne Labs
Ariadne Labs Hospital/Nursing ManagementHealth Services Ariadne Labs provides hospital and healthcare services. It specializes in safe surgery, serious illness care, safe childbirth, primary care, hospitals, health systems innovation, implementation science, informatics, scalable health solutions, checklists, and patient safety. The company was founded by Atul Gawande in 2012 and is headquartered in Boston, MA. | Hospital/Nursing Management | Consultant / Advisor | |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member | |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
Covalence SA (Switzerland)
Covalence SA (Switzerland) Investment ManagersFinance Covalence SA is an independent Swiss investment research firm which was co-founded by Antoine Mach and Marc Rochat in 2001. Headquartered in Carouge, the firm delivers data and research to corporates, academics and non-profits relying on its EthicalQuote reputation index. Their services includes ESG ratings, ESG news data, portfolio advisory, and impact stories, and support sustainable and responsible investment, ESG integration and impact investing strategies. Covalence is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI). | Investment Managers | Consultant / Advisor | |
Pictet Bank & Trust Ltd. (Private Banking)
Pictet Bank & Trust Ltd. (Private Banking) Investment ManagersFinance Pictet Bank & Trust Ltd. (Private Banking) (Pictet Bank & Trust-PB) is the private banking arm of Pictet Bank & Trust Ltd., an offshore bank headquartered in Nassau, Bahamas. The firm was founded in 1978 and is a subsidiary of Banque Pictet & Cie SA, a Swiss private bank which specializes in asset and wealth management. Pictet Bank & Trust-PB provides wealth management and asset servicing for private clients. | Investment Managers | Corporate Officer/Principal | |
SOPHIA GENETICS SA | Packaged Software | Director/Board Member | |
KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 30 |
Zwitserland | 9 |
Canada | 3 |
Duitsland | 3 |
Frankrijk | 3 |
Sectoraal
Health Technology | 30 |
Finance | 8 |
Consumer Services | 4 |
Health Services | 4 |
Miscellaneous | 3 |
Operationeel
Director/Board Member | 140 |
Corporate Officer/Principal | 35 |
Independent Dir/Board Member | 31 |
Chairman | 17 |
Private Equity Investor | 8 |
Sterkste connecties
Insiders | |
---|---|
Michael Powell | 48 |
Stephen Knight | 39 |
John Maraganore | 38 |
Otello Stampacchia | 37 |
Vincent Ossipow | 22 |
Peter Honig | 20 |
Joanne Beck | 12 |
Rajeev Venkayya | 9 |
- Beurs
- Insiders
- Claude Ramoni
- Bedrijfsconnecties